Skip to main content
Top
Literature
1.
go back to reference Tabing AK, Ehrenfeld JM, Wanderer JP. Limiting the accessibility of cost-prohibitive drugs reduces overall anesthetic drug costs: a retrospective before and after analysis. Can J Anesth 2015; 62: 1045-54.CrossRefPubMed Tabing AK, Ehrenfeld JM, Wanderer JP. Limiting the accessibility of cost-prohibitive drugs reduces overall anesthetic drug costs: a retrospective before and after analysis. Can J Anesth 2015; 62: 1045-54.CrossRefPubMed
2.
go back to reference Weinberg L, Story D, Nam J, McNicol L. Pharmacoeconomics of volatile inhalational anaesthetic agents: an 11-year retrospective analysis. Anaesth Intensive Care 2010; 38: 849-54.PubMed Weinberg L, Story D, Nam J, McNicol L. Pharmacoeconomics of volatile inhalational anaesthetic agents: an 11-year retrospective analysis. Anaesth Intensive Care 2010; 38: 849-54.PubMed
3.
go back to reference Golembiewski J. Economic considerations in the use of inhaled anesthetic agents. Am J Health Syst Pharm 2010; 67: S9-12.CrossRefPubMed Golembiewski J. Economic considerations in the use of inhaled anesthetic agents. Am J Health Syst Pharm 2010; 67: S9-12.CrossRefPubMed
4.
go back to reference Chernin EL. Pharmacoeconomics of inhaled anesthetic agents: considerations for the pharmacist. Am J Health Syst Pharm 2004; 61(Suppl 4): S18-22.PubMed Chernin EL. Pharmacoeconomics of inhaled anesthetic agents: considerations for the pharmacist. Am J Health Syst Pharm 2004; 61(Suppl 4): S18-22.PubMed
Metadata
Title
Limiting the accessibility of cost-prohibitive drugs: The story is incomplete
Author
Ian McConachie, MBChB
Publication date
01-03-2016
Publisher
Springer US
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 3/2016
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-015-0531-8

Other articles of this Issue 3/2016

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 3/2016 Go to the issue